Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAGE-547 in Moderate Postpartum Depression
NCT02942017Phase 3Completed
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Start
- Jul 2016
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brexanolone in postpartum depression (PPD), sponsored by Supernus Pharmaceuticals, Inc.. Started Jul 2016; status: completed.
02
Drugs
brexanolone
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT02942017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942017.